Millennial Lithium Corp. Announces Additional License Acquisitions at its Pastos Grandes Project, Argentina to Increase Holdings to 14,091 Hectares

V.ML, Millenial Lithium, lithium, Argentina

Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQX: MLNLF) (“Millennial” or the “Company”) is pleased to announce that it has been successful in a recent Mining Court lottery hearing and was awarded priority rights over the areas covered by PPG 01 (formerly La Union), and PPG 03 (formerly Aguamarga 19) mining licenses (“minas”). The company has exercised those rights and the title transfer is in process. The two new minas are 968.7 hectares (ha) and 394.8 hectares respectively and increase the Company’s landholdings at the Pastos Grandes Salar to approximately 14,091 hectares. The PPG 01 license is just north of the Pastos Grandes Salar and is of strategic importance to the Company for project infrastructure and as a potential supplemental source of fresh water. read more

Gran Colombia Publishes Inaugural ESG Report; Announces May 2021 Production; Declares Monthly Dividend to be Paid on July 15, 2021

T.GCM, Gran Colombia, gold, Colombia

Gran Colombia Gold Corp. (TSX: GCM; OTCQX: TPRFF) announced today that it has published its inaugural ESG report entitled “2020 Sustainability Report” which is available on its website at www.grancolombiagold.com. read more

Tocvan Drills 35.1 meters of 0.72 g/t AuEq in 100 meter Step-out East of the Main Zone at Pilar

CSE:TOC, TocVan Ventures, gold, mexico

Tocvan Ventures Corp. (CSE:TOC) (CNSX:TOC.CN)  (“Tocvan” or the “Corporation”) is pleased to announce results for the next four drill holes from its Phase II drill program (the “Program”) at the Pilar Gold-Silver Project in Sonora, Mexico. A Phase II drill program is currently in progress with 3,500 meters of reverse circulation (RC) drilling in twenty (20) drill holes. Results for four drill holes are included in this release, highlighted by drill hole JES-21-43 which returned 35.1 meters at 0.66 g/t Au and 6 g/t Ag (0.72 g/t AuEq). Thirteen (13) drill holes are pending assay results. read more

Lexaria Drug Delivery Platform Enables up to Three-Fold Increase in Oral Delivery of Antiviral Drugs

DehydraTECH™ improves delivery into bloodstream of orally administered remdesivir and ebastine in study VIRAL-A20-2
Lexaria Bioscience

Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (CSE:LXX) (CNSX:LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce positive results from its tolerability and pharmacokinetic (“PK”) animal study VIRAL-A20-2, evaluating DehydraTECH-enabled remdesivir and ebastine. read more